Home › Funds › TCG Crossover Management, LLC › SLN

TCG Crossover Management, LLC position in SLN

SILENCE THERAPEUTICS PLC · Health Care

TCG Crossover Management, LLC reported holding 3,033,560 shares of SLN (SILENCE THERAPEUTICS PLC) in its Q2 2026 13F filing — a position valued at US$33.3M, representing 0.80% of its reported portfolio and ranking #32 among its reported holdings. TCG Crossover Management, LLC has disclosed SLN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.03M sh
Reported value held$33.31M
Portfolio Weight0.80%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How TCG Crossover Management, LLC's SLN position evolved

TCG Crossover Management, LLC first disclosed a stake in SLN in Q3 2023 at 2,104,875 shares (US$20.7M). The position peaked in Q1 2024 at 3,295,350 shares, worth US$71.2M. Across 12 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 3,033,560 shares valued at US$33.3M. Notable position changes include a 57% increase in Q1 2024 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.10M $20.67M New
Q4 2023 2.10M $36.56M Hold
Q1 2024 3.30M $71.18M Add
Q2 2024 3.30M $62.61M Hold
Q3 2024 3.03M $55.15M Reduce
Q4 2024 3.03M $20.87M Hold
Q1 2025 3.03M $8.55M Hold
Q2 2025 3.03M $17.59M Hold
Q3 2025 3.03M $15.74M Hold
Q4 2025 3.03M $18.44M Hold
Q1 2026 3.03M $15.99M Hold
Q2 2026 3.03M $33.31M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SLN and 13F data

SLN (SILENCE THERAPEUTICS PLC) is a Health Care company. 35 other funds we track also report a position in SLN — the largest reported positions include Siren, L.L.C. (US$36.4M), Redmile Group, LLC (US$23.8M), Nantahala Capital Management, LLC (US$14.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SLN

All SLN fund holders →

FAQ

How long has TCG Crossover Management, LLC held SLN?

TCG Crossover Management, LLC has disclosed SLN holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is TCG Crossover Management, LLC's current position in SLN?

As of Q2 2026, TCG Crossover Management, LLC holds 3.03M shares of SLN (SILENCE THERAPEUTICS PLC), valued at $33.31M, representing 0.80% of its reported portfolio and ranking #32.

Has TCG Crossover Management, LLC been buying or selling SLN?

In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in SLN. The position peaked in Q1 2024 at 3.30M shares.

Which other funds hold SLN?

Other major institutional holders of SLN include Siren, L.L.C., Redmile Group, LLC, Nantahala Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.